Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia (10.1038/s41375- 021-01273-7): SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia (Leukemia, (2021), 35, 9, (2698-2702), 10.1038/s41375-021-01273-7)

Inge van der Werf*, Anna Wojtuszkiewicz, Huilan Yao, Rocco Sciarrillo, Manja Meggendorfer, Stephan Hutter, Wencke Walter, Jeroen Janssen, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach, Gerrit Jansen, Gertjan J. L. Kaspers, Richard Groen, Gert Ossenkoppele, Jacqueline Cloos

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademic

Abstract

Despite carefully proofreading our submission, we missed a mistake in the affiliation of Wolfgang Kern, Claudia Haferlach and Torsten Haferlach. Instead of (2) H3 Biomedicine, their affiliation should be (3) MLL Munich Leukemia Laboratory, Munich, Germany.
Original languageEnglish
Pages (from-to)2735
Number of pages1
JournalLeukemia
Volume35
Issue number9
Early online date2021
DOIs
Publication statusPublished - Sep 2021

Cite this